Reproductive Health

News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.

Aug 23, 2022

Aspira Women's Health Prices $9M Public Offering

Jul 28, 2022

NICE Recommends PerkinElmer, Roche, Quidel Assays for Preeclampsia Testing

Jun 15, 2022

Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflows

Jun 7, 2022

Kindbody Acquires Phosphorus, Plans to Adapt Lab for Fertility Testing

May 24, 2022

ACMG Review Finds NIPS Accurately Detects Common Trisomies in General-Risk Pregnancies

May 17, 2022

Mirvie Raises $60M in Series B Funding

May 12, 2022

Becton Dickinson High-Throughput MDx Module, Triplex STI Test Get FDA 510(k)Clearance

Apr 28, 2022

Mirvie Developing Cell-Free RNA Blood Tests to Predict Pregnancy Complications
Premium

Apr 20, 2022

FDA Cautions of False Results From Prenatal Genetic Tests

Mar 30, 2022

Sera Prognostics Q4, Full-Year Net Loss Swells

Mar 15, 2022

Illumina, Trivitron Healthcare Partner to Expand Use of Diagnostic Sequencing Tests in India

Mar 15, 2022

InfanDx Raises €2M in Series A Second Tranche Funding Round

Mar 9, 2022

Natera Refutes Claims in Short Seller Report After Stock Plummets

Mar 2, 2022

Paper-Based Test Being Developed to Improve Preeclampsia Diagnosis and for Decentralized Settings
Premium

Feb 25, 2022

Natera Hit With Multiple Class Action Suits Over 'Unreliable' NIPT Results

Feb 22, 2022

Women's Health Startup NextGen Jane Gets $1.5M NIH Grant for Endometriosis Test Development

Feb 10, 2022

Swiss Startup Momm Diagnostics Aims to Launch Point-of-Care Preeclampsia Test in 2024
Premium

Jan 18, 2022

Yourgene Inks Deal With EKF Diagnostics to Offer NIPT, Other Genomic Tests in US

Dec 17, 2021

BD Gets CE Mark, Australian Regulatory Approval for New Cor MX Instrument

Dec 9, 2021

Medicover to Buy €44.4M in NIPD Shares, Acquire Majority Stake